Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1843|20|7|1010-1022

ISSN： 1323-7799

Source： RESPIROLOGY (ELECTRONIC), Vol.20, Iss.7, 2015-10, pp. : 1010-1022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular pathogenesis and genetics of osteoarthritis: implications for personalized medicine

By Valdes Ana M  

Personalized Medicine, Vol. 7, Iss. 1, 2010-01 ,pp. : 49-63

Future Medicine

Access to resources Recommend Favorite

Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies

By  

Respiration, Vol. 93, Iss. 6, 2017-05 ,pp. : 379-395

Karger

Access to resources Recommend Favorite

Breath biomarkers for personalized medicine

By Modak Anil S  

Personalized Medicine, Vol. 7, Iss. 6, 2010-11 ,pp. : 643-653

Future Medicine

Access to resources Recommend Favorite

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 252-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Idiopathic Pulmonary Fibrosis: From Epithelial Injury to Biomarkers - Insights from the Bench Side

By  

Respiration, Vol. 86, Iss. 6, 2013-12 ,pp. : 441-452

Karger

Access to resources Recommend Favorite